Reporting possible side effects (UK Patients and Public)
Ninlaro (ixazomib) and
Revlimid (lenalidomide) are subject to additional monitoring. This will allow quick identification
of new safety information. You can help by reporting any side effects you may get. If you get any
side effects whilst taking the Ninlaro regimen, talk to your doctor, pharmacist or nurse. This includes
any possible side effects not listed on this website or in the package leaflets. You can also report
side effects directly via the Yellow Card Scheme at
https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of these medicines.